<p class="MsoNormal">The European Union (EU) health regulator, has launched on Tuesday a “rolling review” for the experimental coronavirus vaccine being co-developed by German pharmaceutical BioNTech and American drugmaker Pfizer in a process that aims to speed up authorization. </p>
